ClinVar Miner

Submissions for variant NM_201525.4(ADGRG1):c.1490T>C (p.Leu497Pro) (rs587783654)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory,University of Chicago RCV000146041 SCV000193196 likely pathogenic Polymicrogyria, bilateral frontoparietal 2013-02-08 criteria provided, single submitter clinical testing
GeneDx RCV000255359 SCV000322516 likely pathogenic not provided 2016-01-20 criteria provided, single submitter clinical testing The L503P variant in the GPR56 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The L503P variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The L503P variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals. In silico analysis predicts this variant is probably damaging to the protein structure/function. The L503P variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.